| Descriptor English: | Insulin Glargine | ||||||
| Descriptor Spanish: |
Insulina Glargina
| ||||||
| Descriptor Portuguese: | Insulina Glargina | ||||||
| Descriptor French: | Insuline glargine | ||||||
| Entry term(s): |
901, HOE A21 Gly B31 Arg B32 Arg insulin A21-Gly-B31-Arg-B32-Arg-insulin Basaglar Glargine Glargine, Insulin Glargine-aglr, Insulin HOE 901 HOE-901 HOE901 Insulin Glargine-aglr Insulin Glargine-yfgn Insulin, Gly(A21)-Arg(B31,B32) Insulin, Glycyl(A21)-Arginyl(B31,B32) Lantus Lantus Solostar Rezvoglar Semglee Solostar, Lantus |
||||||
| Tree number(s): |
D06.472.699.587.200.300.100 D12.644.548.586.200.300.100 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069036 | ||||||
| Scope note: | A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Hypoglycemic Agents |
||||||
| Registry Number: | 2ZM8CX04RZ | ||||||
| Public MeSH Note: | 2016; INSULIN GLARGINE was indexed under INSULIN, LONG ACTING 2011-2015; and under INSULIN 1997-2011 |
||||||
| History Note: | 2016 (1997) |
||||||
| DeCS ID: | 55956 | ||||||
| Unique ID: | D000069036 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2016/01/01 | ||||||
| Date of Entry: | 2015/07/01 | ||||||
| Revision Date: | 2022/04/13 |
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Insulin Glargine
- Preferred
Lantus
- Narrower
Basaglar
- Narrower
HOE 901
- Narrower
Semglee
- Related but not broader or narrower
Insulin Glargine-aglr
- Narrower
| Concept UI |
M0361589 |
| Scope note | A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. |
| Preferred term | Insulin Glargine |
| Entry term(s) |
A21 Gly B31 Arg B32 Arg insulin A21-Gly-B31-Arg-B32-Arg-insulin Glargine Glargine, Insulin Insulin, Gly(A21)-Arg(B31,B32) Insulin, Glycyl(A21)-Arginyl(B31,B32) |
| Concept UI |
M0398522 |
| Preferred term | Lantus |
| Entry term(s) |
Lantus Solostar Solostar, Lantus |
| Concept UI |
M000613204 |
| Preferred term | Basaglar |
| Concept UI |
M0277529 |
| Preferred term | HOE 901 |
| Entry term(s) |
901, HOE HOE-901 HOE901 |
| Concept UI |
M000751185 |
| Preferred term | Semglee |
| Entry term(s) |
Insulin Glargine-yfgn |
| Concept UI |
M000754114 |
| Scope note | A long acting human insulin analog. |
| Preferred term | Insulin Glargine-aglr |
| Entry term(s) |
Glargine-aglr, Insulin Rezvoglar |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
